AI-generated summary
The authors tested intracranial near-infrared light delivered to the midbrain of 6-OHDA-lesioned rats, a model of Parkinson's disease, using two powers and two delivery modes. They report that the stronger power reduced apomorphine-induced rotations, with neuroprotection partly accounting for the behavioral changes, and no midbrain tissue toxicity was found. Limits stated include that this is an animal study and that other symptomatic effects may have contributed.
- Who or what was studied
- 6-hydroxydopamine-lesioned Wistar rats used as a model of Parkinson's disease
- Limits stated in the abstract
- This is an animal study, and the abstract notes that other symptomatic effects may have contributed to the behavioral improvements beyond neuroprotection.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on thejns.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 0.16 mW
- Total energy
- 304 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.